Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.69% |
| 2 | Technology | 13.64% |
| 3 | Financials | 12.49% |
| 4 | Consumer Discretionary | 10.83% |
| 5 | Industrials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KA
2326
DELISTED
Kineta, Inc. Common Stock
KA
| $1.56M | ﹤0.01% |
+3,451
| New | +$2.34M |
|
|
ARE.PRD
2327
DELISTED
Alexandria Real Estate Equities Inc 7.00% Series D Preferred Stock
ARE.PRD
| $1.56M | ﹤0.01% |
46,627
| – | – |
|
|
CARM
2328
DELISTED
Carisma Therapeutics
CARM
| $1.56M | ﹤0.01% |
54,995
+13,493
| +33% | +$430K |
|
2329
iShares Russell 2000 Growth ETF
IWO
$15B
| $1.56M | ﹤0.01% |
9,300
-2,931
| -24% | -$547K |
|
|
GES
2330
DELISTED
Guess Inc
GES
| $1.56M | ﹤0.01% |
75,148
-60,569
| -45% | -$1.28M |
|
2331
FNB Corp
FNB
$6.6B
| $1.55M | ﹤0.01% |
157,784
+66,492
| +73% | +$771K |
|
2332
Omnicell
OMCL
$1.53B
| $1.55M | ﹤0.01% |
+25,354
| New | +$1.72M |
|
2333
1-800-Flowers.com
FLWS
$240M
| $1.55M | ﹤0.01% |
+126,749
| New | +$1.52M |
|
2334
ICF International
ICFI
$1.59B
| $1.55M | ﹤0.01% |
23,907
-2,127
| -8% | -$149K |
|
2335
CALL
Danaher
DHR
$152B
| $1.55M | ﹤0.01% |
+16,920
| New | +$1.54M |
|
2336
TAL Education Group
TAL
$6.5B
| $1.55M | ﹤0.01% |
57,973
-375,321
| -87% | -$9.96M |
|
2337
Quaker Houghton
KWR
$2.83B
| $1.54M | ﹤0.01% |
8,687
+4,727
| +119% | +$911K |
|
2338
Liberty Global Class A
LBTYA
$3.65B
| $1.54M | ﹤0.01% |
72,340
-249,045
| -77% | -$6.11M |
|
2339
Ball Corp
BALL
$17B
| $1.54M | ﹤0.01% |
33,457
-996,006
| -97% | -$46.5M |
|
2340
Noodles & Co
NDLS
$90.9M
| $1.54M | ﹤0.01% |
27,477
+8,067
| +42% | +$600K |
|
2341
iShares Russell 3000 ETF
IWV
$20.2B
| $1.53M | ﹤0.01% |
10,435
+7,223
| +225% | +$1.15M |
|
|
HMSY
2342
DELISTED
HMS Holdings Corp.
HMSY
| $1.53M | ﹤0.01% |
54,499
-6,571
| -11% | -$213K |
|
2343
American Vanguard Corp
AVD
$66.7M
| $1.53M | ﹤0.01% |
+100,550
| New | +$1.66M |
|
2344
Vanguard FTSE All-World ex-US ETF
VEU
$70.8B
| $1.53M | ﹤0.01% |
33,503
-20,017
| -37% | -$961K |
|
|
VSI
2345
DELISTED
Vitamin Shoppe Inc.
VSI
| $1.53M | ﹤0.01% |
321,842
-556,386
| -63% | -$4.18M |
|
|
SPPI
2346
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $1.52M | ﹤0.01% |
174,058
+120,541
| +225% | +$1.54M |
|
|
DSPG
2347
DELISTED
DSP Group Inc
DSPG
| $1.52M | ﹤0.01% |
135,982
-213,743
| -61% | -$2.5M |
|
2348
TriCo Bancshares
TCBK
$1.74B
| $1.52M | ﹤0.01% |
+45,039
| New | +$1.62M |
|
|
OXFD
2349
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $1.51M | ﹤0.01% |
117,914
+63,617
| +117% | +$965K |
|
|
HIVE
2350
DELISTED
Aerohive Networks
HIVE
| $1.5M | ﹤0.01% |
461,526
-83,679
| -15% | -$315K |
|
Similar funds
Israel Englander's Q4 2018 Portfolio in Review
As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.
- Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Israel Englander opened 702 new positions and closed 844 in Q4 2018.
- Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.